Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of Scans Without Evidence of Dopaminergic Deficit (SWEDDs)

The clinical diagnosis of Parkinson's disease (PD) is susceptible to misdiagnosis, especially in the earlier stages of the disease. Recently, in vivo imaging techniques assessing the presynaptic dopamine transporter (DAT) have emerged as a useful tool in PD diagnosis, improving its accuracy. OB...

ver descrição completa

Detalhes bibliográficos
Autores: Utiumi, Marco A. T., Felício, André Carvalho [UNIFESP], Borges, Conrado R., Braatz, Vera L., Rezende, Sheyla A. S., Munhoz, Renato P., Bressan, Rodrigo Affonseca [UNIFESP], Ferraz, Henrique B. [UNIFESP], Teive, Hélio A. G.
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2012
País:Brasil
Recursos:Universidade Federal de São Paulo (UNIFESP)
Repositório:Repositório Institucional da UNIFESP
Idioma:inglês
OAI Identifier:oai:repositorio.unifesp.br:11600/7307
Acesso em linha:http://dx.doi.org/10.1590/S0004-282X2012000900004
http://repositorio.unifesp.br/handle/11600/7307
Access Level:Acceso aberto
Palavra-chave:Parkinson disease
scans without evidence of dopaminergic deficit
tomography
emission-computed
single-photon
Tc-99mtrodat- 1
dopamine transporter
doença de Parkinson
exames sem evidência de déficit dopaminérgico
tomografia computadorizada de emissão de fóton único
Tc-99m-trodat-1
transportador de dopamina
Descrição
Resumo:The clinical diagnosis of Parkinson's disease (PD) is susceptible to misdiagnosis, especially in the earlier stages of the disease. Recently, in vivo imaging techniques assessing the presynaptic dopamine transporter (DAT) have emerged as a useful tool in PD diagnosis, improving its accuracy. OBJECTIVE: It was to illustrate the clinical usefulness of a brain single-photon emission computed tomography (SPECT) DAT ligand, and highlight relevant aspects of scans without evidence of dopaminergic deficit (SWEDDs) in this context. CASES: We described four representative patients with clinically unclear parkinsonian syndromes who underwent [99mTc]-TRODAT-1 SPECT and reviewed the clinical implications. CONCLUSION: DAT-SPECT is an important, cost-effective, technique for the differential diagnosis of parkinsonian syndromes. Additionally, SWEDD cases present clinical and paraclinical peculiarities that may retrospectively identify them as essential/dystonic tremor. The lack of histopathological data limits further conclusions.